Manufacturing Daily Summary
Manufacturing Daily Summary: What Happened on November 4, 2026
Wacker Biotech adds newer RNA formats to manufacturing services
Its offering spans nucleic-acid development, formulation and GMP production.
Today in brief
Wacker Biotech offers an integrated platform for nucleic-acid medicines, from plasmid DNA and RNA through lipid nanoparticle formulation, analytical development and GMP manufacturing.1 It has supplied clinical material for two RNA vaccine candidates that reached Phase III, and says customers can use one partner instead of coordinating multiple vendors.1
Also worth knowing
-
Wacker Biotech has added circular RNA, self-amplifying RNA and siRNA capabilities, and launched Contract Research Services at its Munich research center in 2026.1